“Does Tylenol in Pregnancy Cause Autism?” – with Emily Oster

Few questions cause more anxiety during pregnancy than whether common medications are safe for a developing baby. The claim that Tylenol use during pregnancy may cause autism has circulated widely, leaving many expectant parents uncertain and afraid. In a recent episode of the Healthful Woman podcast, Dr. Nathan Fox spoke with economist and data researcher Emily Oster to examine the actual evidence behind this claim, and what they found offers important reassurance grounded in rigorous science.

If you have questions about medication safety or high-risk pregnancy care, our team is here to help. Call us for details to schedule a consultation with one of our award-recognized providers.

Where the Concern About Tylenol in Pregnancy Came From

The concern linking Tylenol, known generically as acetaminophen, to autism spectrum disorder and ADHD in children gained significant public attention following a 2021 consensus statement signed by a group of researchers. That statement called for precautionary guidance around acetaminophen use during pregnancy, and it was widely covered in the media.

The studies underlying those concerns relied primarily on observational data. Researchers asked parents to recall how much Tylenol they used during pregnancy, then looked at neurodevelopmental outcomes in their children. The challenge with this approach is substantial: it cannot account for why a person was taking Tylenol in the first place. Fever, pain, and infection during pregnancy are themselves associated with adverse outcomes. If a person took Tylenol because they had a high fever or a significant infection, any observed differences in child outcomes may reflect the underlying condition rather than the medication.

As Emily Oster explained on the podcast, this is a classic problem of confounding in epidemiology. When studies fail to adequately separate the effect of a drug from the effect of the condition it is treating, the conclusions can be misleading. This methodological limitation is central to understanding why the Tylenol-autism claim does not hold up under closer scrutiny.

Why Sibling-Comparison Studies Offer a Clearer Answer on Pregnancy Outcomes

One of the most valuable tools for cutting through confounding in pregnancy research is the sibling-comparison study design. Rather than comparing unrelated children across different families, researchers compare siblings within the same family, one of whom was exposed to a substance in utero and one of whom was not.

This design is powerful because it controls for many variables that are otherwise difficult to measure, including genetic predisposition to autism, household environment, socioeconomic factors, and parental health behaviors. Families that use Tylenol during one pregnancy are likely to have similar characteristics across all their pregnancies.

When researchers applied this sibling-comparison approach to the Tylenol question, the apparent association between acetaminophen use during pregnancy and autism or ADHD largely disappeared. Emily Oster walked through this evidence in detail on the podcast, noting that the higher-quality studies consistently produce weaker or null associations. As she summarized, the best available data does not support the conclusion that Tylenol causes autism.

For patients navigating decisions about pain or fever management during pregnancy, this distinction matters enormously. Untreated high fever during pregnancy carries documented risks to fetal development. Avoiding a well-studied medication out of fear generated by flawed research can itself create harm.

The Real Consequences of Pregnancy Misinformation

The podcast conversation between Dr. Fox and Emily Oster extended beyond the data itself to address a broader and equally important issue: what happens when misinformation spreads among pregnant patients.

When observational studies with significant methodological limitations are reported as settled findings, the downstream effects are real. Parents, particularly mothers, internalize guilt over every decision made during pregnancy. Patients avoid treating fevers or managing pain adequately because they fear they will cause harm to their child. In some cases, this avoidance may itself contribute to worse outcomes.

Emily Oster, whose work focuses on helping people interpret data clearly, emphasized that science literacy is not about dismissing concerns. It is about proportionality, evaluating the quality of evidence, not just its existence. A study that shows a correlation in unadjusted data is not the same as a study that demonstrates causation through rigorous design.

Dr. Fox echoed this sentiment, noting that a core part of pregnancy care is helping patients make informed decisions without unnecessary fear. Our practice takes the same approach: we discuss the evidence with patients directly, help contextualize risk accurately, and support informed decision-making throughout every stage of pregnancy. Providers at our practice have been recognized among New York’s top physicians, and that standard of care includes giving patients clear, evidence-based answers to difficult questions.

Why Choose Our Practice for Your Pregnancy Care

Our providers have received recognition from Castle Connolly Top Doctors, Super Doctors, New York Best Doctors, and U.S. News and World Report as part of a High Performing Hospital for Maternity Care. These distinctions reflect a consistent commitment to clinical excellence and patient-centered care.

As members of the U.S. Women’s Health Alliance and a Rainbow Practice, we bring together the depth of academic medicine with the accessibility and personal attention of private practice. Our team specializes in high-risk obstetrics and maternal-fetal medicine, offering comprehensive services including high-risk pregnancy care, genetic carrier screening, and advanced ultrasound services.

For patients in the New York area navigating complex questions about pregnancy safety, medication use, or fetal health, our providers offer the experience and credentials to guide you with clarity and confidence.

Is Tylenol safe to take during pregnancy?

Acetaminophen has been used during pregnancy for decades and remains one of the most studied over-the-counter medications in this population. Current evidence from high-quality studies, including sibling-comparison research, does not establish a causal link between acetaminophen use and autism or ADHD. That said, all medication decisions during pregnancy should be made in consultation with your provider based on your individual circumstances.

What made the original studies linking Tylenol to autism problematic?

The majority of studies raising this concern relied on self-reported, observational data that could not adequately control for the conditions that prompted Tylenol use in the first place. High fever, pain, and infection are themselves associated with adverse pregnancy outcomes. When more rigorous sibling-comparison study designs were applied, the association largely disappeared, suggesting the earlier findings reflected confounding rather than causation.

Should I avoid all medications during pregnancy?

Not necessarily. Untreated fever, infection, and significant pain during pregnancy carry their own documented risks. Avoiding treatment based on misinformation may create greater risk than the medication itself. The goal is informed decision-making based on the best available evidence. Your provider can help you weigh the benefits and risks of any medication relative to your specific health situation during pregnancy.

What is a sibling-comparison study and why does it matter for pregnancy research?

A sibling-comparison study examines outcomes in siblings within the same family, where one child was exposed to a substance in utero and another was not. This design controls for many shared factors including genetics, environment, and parental behavior, making it harder for confounding variables to distort results. In pregnancy research, this approach provides a clearer picture of whether a specific exposure, rather than background risk, drives an outcome.

What services does your practice offer for pregnancy care?

Our practice provides high-risk pregnancy care, high-risk obstetrics, genetic carrier screening, and ultrasound services. Our providers specialize in maternal-fetal medicine and have received recognition from Castle Connolly, U.S. News and World Report, and other leading organizations. Learn more about our maternal-fetal medicine services or call for details to schedule a consultation.

If you have questions about medication safety, genetic screening, or any aspect of your pregnancy, our team is ready to help. Our New York providers bring award-recognized expertise in high-risk pregnancy care to every patient consultation. Call us for details to connect with a provider who can offer clear, evidence-based guidance for your pregnancy journey. Individual results and circumstances vary; please consult with your provider for personalized medical advice.

Maternal Fetal Medicine blogs are intended for educational purposes only and do not replace certified professional care. Medical conditions vary and change frequently. Please ask your doctor any questions you may have regarding your condition to receive a proper diagnosis or risk analysis. Thank you!